MTOR and autosomal dominant polycystic kidney disease: Biochemical pathways that drive cystogenesis, including cell cycle progression, apoptosis, mitogenic signaling, Akt‐mTOR activity, and Wnt signaling activity, are changed similarly in the Pkd1 cKO and human ADPKD kidneys.